Mia's Feed
Medical News & Research

Innovative Pen-Like Device for Rapid Detection of Opioids via Skin Analysis

Innovative Pen-Like Device for Rapid Detection of Opioids via Skin Analysis

Share this article

A novel pen-shaped device offers rapid, non-invasive detection of opioids from the skin using mass spectrometry, promising to enhance overdose screening and intervention efforts.

2 min read

A groundbreaking technological advancement presented in boratory Analytical Chemistryids in the fight against opioid overdose crises. Researchers have developed a portable, pen-shaped device capable of quickly and non-invasively extracting and analyzing molecules from the skin's surface to detect opioid substances, such as fentanyl, morphine, and oxycodone.

Opioids are the primary drugs associated with overdose fatalities in the United States, often detected through blood, saliva, or urine tests, which can be time-consuming and require laboratory processing. This new tool, inspired by the clinical MasSpec Pen technology used in cancer tissue analysis, offers a rapid alternative by directly sampling the skin.

The modified MasSpec Pen works by depositing a tiny droplet of water and ethanol onto the skin, which then collects molecules indicative of opioid use over a span of just three seconds. The collected sample is immediately aspirated into a collection vial and can be analyzed on-site using mass spectrometry highly sensitive method for molecular detection. If needed, samples can also be stored for later examination.

Initial testing demonstrated promising results. When applied to volunteers with known opioid exposure, the device detected fentanyl in seven out of eight skin samples, compared to its presence in all urine samples and in some saliva samples. Although the detection levels from skin samples were lower than traditional biological fluids, the device's ease of use and portability highlight its potential for field or clinical applications.

The researchers acknowledge factors such as skin type, cleanliness, and timing of drug intake may influence results and plan further studies to optimize detection limits and expand understanding. Some of the team members hold patents related to the MasSpec Pen and are involved in commercializing this technology.

This development could enable earlier interventions for individuals at risk of overdose or requiring substance use treatment, providing a quick, non-invasive, and accessible screening method outside traditional laboratory settings.

Source: https://medicalxpress.com/news/2025-06-handy-pen-tool-opioids-skin.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Evolving Methods for Gestational Diabetes Testing in Pregnant Women

Australia introduces updated guidelines for gestational diabetes screening, focusing on targeted testing to improve outcomes and reduce unnecessary interventions in pregnant women.

Study Uses AI to Uncover Disparities in Amputation Rates Among Rural and Minoritized Populations

A new study employing AI uncovers the role of implicit bias in disparities of limb amputation rates among rural and minoritized populations with vascular disease, highlighting the need for equitable treatment guidelines.

Economic Benefits of Widespread COVID-19 Vaccination, Particularly for Older Adults, Highlighted by New Study

A new study highlights the significant economic advantages of broad COVID-19 vaccination, particularly for seniors, by preventing hospitalizations, deaths, and long-term health costs. Learn how increased vaccination coverage can save money and improve public health.

Study Finds Tumor-Related Epilepsy Is Not a Major Prognostic Indicator in Diffuse Glioma Patients

New research indicates that tumor-related epilepsy does not serve as a significant prognostic factor in patients with diffuse gliomas, highlighting complex tumor-brain interactions affecting outcomes.